Withdrawal of Approval of New Animal Drug Applications; Roxarsone
other · Food and Drug Administration · Rule · Published 2013-12-27 · Effective 2014-01-06 · 78 FR 78716
Document
Document number
2013-30837
Federal Register citation
78 FR 78716
CFR reference
21 CFR 520
Type
Rule
Action
Notice of withdrawal.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2013-12-27
Effective date
2014-01-06
HHS docket
Docket No. FDA-2013-N-0002
Abstract
The Food and Drug Administration (FDA) is withdrawing approval of five new animal drug applications (NADAs) for roxarsone oral dosage form products at the sponsor's request because the products are no longer manufactured or marketed.